Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 46 member 1 | 0.606 | 0.731 | 2.2E-02 |
|
disease | 0.600 | None | 1.000 | 2 | 0 | 2007 | 2011 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.430 | strong | 0.750 | 1 | 0 | 2015 | 2019 | ||||||||
|
DnaJ heat shock protein family (Hsp40) member C21 | 0.606 | 0.731 | 2.1E-07 |
|
disease | 0.420 | strong | 1.000 | 2 | 1 | 2016 | 2018 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.420 | strong | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
FA complementation group C | 0.507 | 0.808 | 2.8E-13 |
|
disease | 0.410 | strong | 1.000 | 3 | 0 | 1992 | 2016 | ||||||||
|
transcobalamin 2 | 0.578 | 0.615 | 1.0E-06 |
|
disease | 0.400 | strong | 1.000 | 3 | 0 | 1999 | 2009 | ||||||||
|
dihydrofolate reductase | 0.513 | 0.808 | 3.4E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
SLX4 structure-specific endonuclease subunit | 0.565 | 0.731 | 1.6E-22 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
FA complementation group E | 0.553 | 0.808 | 1.5E-06 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.350 | None | 0.857 | 2 | 0 | 1997 | 2020 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2012 | 2018 | ||||||||
|
FA complementation group G | 0.556 | 0.769 | 2.5E-14 |
|
disease | 0.320 | strong | 1.000 | 3 | 0 | 1998 | 2019 | ||||||||
|
Myb like, SWIRM and MPN domains 1 | 0.700 | 0.462 | 4.3E-02 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2017 | 2018 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1997 | 2018 | ||||||||
|
FA complementation group M | 0.543 | 0.731 | 2.4E-15 |
|
disease | 0.310 | moderate | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2017 | 2018 | ||||||||
|
exocyst complex component 3 like 2 | 0.722 | 0.500 | 0.76 |
|
disease | 0.300 | strong | 1.000 | 2 | 0 | 2016 | 2019 | ||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ribosomal protein L27a | 0.890 | 0.115 | 0.91 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
RAD51 paralog C | 0.533 | 0.692 | 6.2E-14 |
|
disease | 0.300 | moderate | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
molybdenum cofactor sulfurase | 0.617 | 0.654 | 1.6E-19 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2017 | 2017 |